Filtros : "PLASMODIUM" "Vaccine" Removido: "IMT-IMT" Limpar

Filtros



Refine with date range


  • Source: Vaccine. Unidades: ICB, FCF

    Subjects: MALÁRIA, VACINAS, PLASMODIUM

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARQUES, Rodolfo Ferreira et al. Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant. Vaccine, v. 42, n. 9, p. 2394-2406, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.vaccine.2024.02.070. Acesso em: 11 out. 2024.
    • APA

      Marques, R. F., Gimenez, A. M., Caballero, O., Simpson, A., Salazar, A. M., Amino, R., et al. (2024). Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant. Vaccine, 42( 9), 2394-2406. doi:10.1016/j.vaccine.2024.02.070
    • NLM

      Marques RF, Gimenez AM, Caballero O, Simpson A, Salazar AM, Amino R, Godin S, Gazzinelli RT, Soares I da S. Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant [Internet]. Vaccine. 2024 ; 42( 9): 2394-2406.[citado 2024 out. 11 ] Available from: https://dx.doi.org/10.1016/j.vaccine.2024.02.070
    • Vancouver

      Marques RF, Gimenez AM, Caballero O, Simpson A, Salazar AM, Amino R, Godin S, Gazzinelli RT, Soares I da S. Non-clinical toxicity and immunogenicity evaluation of a Plasmodium vivax malaria vaccine using Poly-ICLC (Hiltonol®) as adjuvant [Internet]. Vaccine. 2024 ; 42( 9): 2394-2406.[citado 2024 out. 11 ] Available from: https://dx.doi.org/10.1016/j.vaccine.2024.02.070
  • Source: Vaccine. Unidade: FCF

    Subjects: MALÁRIA, PLASMODIUM

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ROCHA, Mariana Vilela et al. Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and 'MSP1 IND.19'. Vaccine, v. 35, p. 2463-2472, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2017.03.023. Acesso em: 11 out. 2024.
    • APA

      Rocha, M. V., Françoso, K. S., Lima, L. C., Camargo, T. M., Machado, R. L. D., Costa, F. T. M., et al. (2017). Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and 'MSP1 IND.19'. Vaccine, 35, 2463-2472. doi:10.1016/j.vaccine.2017.03.023
    • NLM

      Rocha MV, Françoso KS, Lima LC, Camargo TM, Machado RLD, Costa FTM, Rénia L, Nosten F, Russell B, Rodrigues MM, Soares I da S. Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and 'MSP1 IND.19' [Internet]. Vaccine. 2017 ; 35 2463-2472.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.vaccine.2017.03.023
    • Vancouver

      Rocha MV, Françoso KS, Lima LC, Camargo TM, Machado RLD, Costa FTM, Rénia L, Nosten F, Russell B, Rodrigues MM, Soares I da S. Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and 'MSP1 IND.19' [Internet]. Vaccine. 2017 ; 35 2463-2472.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.vaccine.2017.03.023
  • Source: Vaccine. Unidade: FCF

    Subjects: MALÁRIA, PLASMODIUM, VACINAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GENTIL, Fernanda et al. A recombinant vaccine based on domain II of Plasmodium vivax apical membrane antigen 1 induces high antibody titres in mice. Vaccine, v. 28, n. 38, p. 6183-6190, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2010.07.017. Acesso em: 11 out. 2024.
    • APA

      Gentil, F., Bargieri, D. Y., Leite, J. A., Françoso, K. S., Patricio, M. B. de M., Espindola, N. M., et al. (2010). A recombinant vaccine based on domain II of Plasmodium vivax apical membrane antigen 1 induces high antibody titres in mice. Vaccine, 28( 38), 6183-6190. doi:10.1016/j.vaccine.2010.07.017
    • NLM

      Gentil F, Bargieri DY, Leite JA, Françoso KS, Patricio MB de M, Espindola NM, Vaz AJ, Palatnik-de-Sousa CB, Rodrigues MM, Costa FTM, Soares I da S. A recombinant vaccine based on domain II of Plasmodium vivax apical membrane antigen 1 induces high antibody titres in mice [Internet]. Vaccine. 2010 ; 28( 38): 6183-6190.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.vaccine.2010.07.017
    • Vancouver

      Gentil F, Bargieri DY, Leite JA, Françoso KS, Patricio MB de M, Espindola NM, Vaz AJ, Palatnik-de-Sousa CB, Rodrigues MM, Costa FTM, Soares I da S. A recombinant vaccine based on domain II of Plasmodium vivax apical membrane antigen 1 induces high antibody titres in mice [Internet]. Vaccine. 2010 ; 28( 38): 6183-6190.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.vaccine.2010.07.017
  • Source: Vaccine. Unidade: FCF

    Subjects: PLASMODIUM, VACINAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BUENO, Lilian Lacerda et al. Plasmodium vivax recombinant vaccine candidate AMA-1 plays an important role in adaptive immune response eliciting differentiation of dendritic cells. Vaccine, v. 27, n. 41, p. 5581-5588, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2009.07.031. Acesso em: 11 out. 2024.
    • APA

      Bueno, L. L., Morais, C. G., Soares, I. da S., Bouillet, L. E. M., Bruna-Romero, O., Fontes, C. J., et al. (2009). Plasmodium vivax recombinant vaccine candidate AMA-1 plays an important role in adaptive immune response eliciting differentiation of dendritic cells. Vaccine, 27( 41), 5581-5588. doi:10.1016/j.vaccine.2009.07.031
    • NLM

      Bueno LL, Morais CG, Soares I da S, Bouillet LEM, Bruna-Romero O, Fontes CJ, Fujiwara RT, Braga ÉM. Plasmodium vivax recombinant vaccine candidate AMA-1 plays an important role in adaptive immune response eliciting differentiation of dendritic cells [Internet]. Vaccine. 2009 ; 27( 41): 5581-5588.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.vaccine.2009.07.031
    • Vancouver

      Bueno LL, Morais CG, Soares I da S, Bouillet LEM, Bruna-Romero O, Fontes CJ, Fujiwara RT, Braga ÉM. Plasmodium vivax recombinant vaccine candidate AMA-1 plays an important role in adaptive immune response eliciting differentiation of dendritic cells [Internet]. Vaccine. 2009 ; 27( 41): 5581-5588.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.vaccine.2009.07.031
  • Source: Vaccine. Unidade: FCF

    Subjects: PLASMODIUM, VACINAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BUENO, Lilian Lacerda et al. Direct effect of Plasmodium vivax recombinant vaccine candidates AMA-1 and 'MSP-1 IND. 19' on the innate immune response. Vaccine, v. 26, n. 9, p. 1204-1213, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2007.12.031. Acesso em: 11 out. 2024.
    • APA

      Bueno, L. L., Fujiwara, R. T., Soares, I. da S., & Braga, É. M. (2008). Direct effect of Plasmodium vivax recombinant vaccine candidates AMA-1 and 'MSP-1 IND. 19' on the innate immune response. Vaccine, 26( 9), 1204-1213. doi:10.1016/j.vaccine.2007.12.031
    • NLM

      Bueno LL, Fujiwara RT, Soares I da S, Braga ÉM. Direct effect of Plasmodium vivax recombinant vaccine candidates AMA-1 and 'MSP-1 IND. 19' on the innate immune response [Internet]. Vaccine. 2008 ;26( 9): 1204-1213.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.vaccine.2007.12.031
    • Vancouver

      Bueno LL, Fujiwara RT, Soares I da S, Braga ÉM. Direct effect of Plasmodium vivax recombinant vaccine candidates AMA-1 and 'MSP-1 IND. 19' on the innate immune response [Internet]. Vaccine. 2008 ;26( 9): 1204-1213.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/j.vaccine.2007.12.031
  • Source: Vaccine. Unidade: FCF

    Subjects: IMUNOLOGIA, PLASMODIUM, PROTEÍNAS RECOMBINANTES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CUNHA, Martistela G. e RODRIGUES, Mauricio M. e SOARES, Irene da Silva. Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate 'MSP1 IND. 19' expressed in distinct bacterial vectors. Vaccine, v. 20, n. 3-4, p. 385-396, 2002Tradução . . Disponível em: https://doi.org/10.1016/s0264-410x(01)00359-0. Acesso em: 11 out. 2024.
    • APA

      Cunha, M. G., Rodrigues, M. M., & Soares, I. da S. (2002). Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate 'MSP1 IND. 19' expressed in distinct bacterial vectors. Vaccine, 20( 3-4), 385-396. doi:10.1016/s0264-410x(01)00359-0
    • NLM

      Cunha MG, Rodrigues MM, Soares I da S. Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate 'MSP1 IND. 19' expressed in distinct bacterial vectors [Internet]. Vaccine. 2002 ; 20( 3-4): 385-396.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/s0264-410x(01)00359-0
    • Vancouver

      Cunha MG, Rodrigues MM, Soares I da S. Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate 'MSP1 IND. 19' expressed in distinct bacterial vectors [Internet]. Vaccine. 2002 ; 20( 3-4): 385-396.[citado 2024 out. 11 ] Available from: https://doi.org/10.1016/s0264-410x(01)00359-0

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024